Clopidogrel versus ticagrelor on coronary microvascular and peripheral endothelial function after non-ST elevation acute coronary syndrome: a randomised trial

被引：0
|
作者：
Xu, J. [1 ]
Lo, S. [1 ]
Mussap, C. [1 ]
French, J. [1 ]
Rajaratnam, R. [1 ]
Kadappu, K. [2 ]
Premawardhana, U. [2 ]
Nguyen, P. [2 ]
Juergens, C. [1 ]
Leung, D. [1 ]
机构：
[1] Liverpool Hosp, Dept Cardiol, Sydney, NSW, Australia
[2] Campbelltown Hosp, Dept Cardiol, Sydney, NSW, Australia
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2708
引用
收藏
页码：1659 / 1659
页数：1
相关论文
共 50 条
  • [21] Ticagrelor vs. clopidogrel in non-ST-elevation acute coronary syndromes
    Ren, Q.
    Ren, C.
    Liu, X.
    Dong, C.
    Zhang, X.
    [J]. HERZ, 2016, 41 (03) : 246 - 249
  • [22] EARLY INVASIVESTRATEGY FOR NON-ST ELEVATION ACUTE CORONARY SYNDROME - A SINGLE INSTITUE TRIAL
    Hisn, Ho-Tsung
    Li, Ai-Hsian
    Yeih, Dong-Feng
    Lai, Chao-Lun
    Chen, Kuo-Chin
    Liu, Yuan-Hung
    Lo, Hsein-Jung
    Wang, Ying-Chieh
    Yang, Chi-Yu
    Chu, Shu- Hsun
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 97 : S35 - S35
  • [23] REPLY: Prasugrel Versus Ticagrelor in Non-ST-Segment-Elevation Acute Coronary Syndrome
    Neumann, Franz-Josef
    Valina, Christian
    Kastrati, Adnan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (11) : 1484 - 1484
  • [24] Pharmacokinetics and pharmacodynamics of ticagrelor when treating non-ST elevation acute coronary syndromes
    Monitillo, Francesco
    Iacoviello, Massimo
    Caldarola, Pasquale
    Valle, Roberto
    Chiatto, Mario
    Aspromonte, Nadia
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (06) : 977 - 993
  • [25] Randomised trial to compare a protective effect of Clopidogrel Versus TIcagrelor on coronary Microvascular injury in ST-segment Elevation myocardial infarction (CV-TIME trial)
    Park, Sang-Don
    Lee, Man-Jong
    Baek, Yong-Soo
    Kwon, Sung-Woo
    Shin, Sung-Hee
    Woo, Seong-Ill
    Kim, Dae-Hyeok
    Kwan, Jun
    Park, Keum-Soo
    [J]. EUROINTERVENTION, 2016, 12 (08) : E964 - E971
  • [26] Heparin versus placebo for non-ST elevation acute coronary syndromes
    Andrade-Castellanos, Carlos A.
    Colunga-Lozano, Luis E.
    Delgado-Figueroa, Netzahualpilli
    Magee, Kirk
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (06):
  • [27] Impact of Anticoagulation on Coronary Flow in Patients With Non-ST Elevation Acute Coronary Syndrome
    Kang, Jeehoon
    Cho, Young-Seok
    Song, Hee Yun
    Kim, Hyun Jin
    Oh, Il-Young
    Yoon, Chang-Hwan
    Suh, Jung-Won
    Kim, Kwang-Il
    Chung, Woo-Young
    Youn, Tae-Jin
    Chae, In-Ho
    Choi, Dong-Ju
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (01) : 48 - 57
  • [28] Cost-effectiveness of clopidogrel versus ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome
    Van den Broek, W. W. A.
    Van Paassen, J. G.
    Gimbel, M. E.
    Deneer, V. H. M.
    Ten Berg, J. M.
    Vreman, R. A.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 2846 - 2846
  • [29] Fondaparinux and Invasive Treatment of Non-ST Elevation Acute Coronary Syndrome
    Averkov, O. V.
    [J]. KARDIOLOGIYA, 2008, 48 (12) : 49 - 54
  • [30] THE STRATEGY OF MANAGEMENT PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME
    Prilutskaya, Y. A.
    Dvoretski, L., I
    [J]. KARDIOLOGIYA, 2019, 59 (09) : 40 - 51
12345